EP1534852A4 - CSNK1GS ALS MODIFIKATOREN DES p21-WEGS UND VERWENDUNGSVERFAHREN - Google Patents

CSNK1GS ALS MODIFIKATOREN DES p21-WEGS UND VERWENDUNGSVERFAHREN

Info

Publication number
EP1534852A4
EP1534852A4 EP03784937A EP03784937A EP1534852A4 EP 1534852 A4 EP1534852 A4 EP 1534852A4 EP 03784937 A EP03784937 A EP 03784937A EP 03784937 A EP03784937 A EP 03784937A EP 1534852 A4 EP1534852 A4 EP 1534852A4
Authority
EP
European Patent Office
Prior art keywords
csnk1gs
modifiers
pathway
genes
csnk1gs genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03784937A
Other languages
English (en)
French (fr)
Other versions
EP1534852A2 (de
Inventor
Helen Francis-Lang
Lori Friedman
Thomas Kidd
Siobhan Roche
Haiguang Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exelixis Inc
Original Assignee
Exelixis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis Inc filed Critical Exelixis Inc
Publication of EP1534852A2 publication Critical patent/EP1534852A2/de
Publication of EP1534852A4 publication Critical patent/EP1534852A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/60—New or modified breeds of invertebrates
    • A01K67/61—Genetically modified invertebrates, e.g. transgenic or polyploid
    • A01K67/65—Genetically modified arthropods
    • A01K67/68—Genetically modified insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/70—Invertebrates
    • A01K2227/706—Insects, e.g. Drosophila melanogaster, medfly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP03784937A 2002-08-07 2003-08-06 CSNK1GS ALS MODIFIKATOREN DES p21-WEGS UND VERWENDUNGSVERFAHREN Withdrawn EP1534852A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40173902P 2002-08-07 2002-08-07
US401739P 2002-08-07
PCT/US2003/024551 WO2004015071A2 (en) 2002-08-07 2003-08-06 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE

Publications (2)

Publication Number Publication Date
EP1534852A2 EP1534852A2 (de) 2005-06-01
EP1534852A4 true EP1534852A4 (de) 2006-09-20

Family

ID=31715726

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03784937A Withdrawn EP1534852A4 (de) 2002-08-07 2003-08-06 CSNK1GS ALS MODIFIKATOREN DES p21-WEGS UND VERWENDUNGSVERFAHREN

Country Status (6)

Country Link
US (1) US20050251870A1 (de)
EP (1) EP1534852A4 (de)
JP (1) JP2005534334A (de)
AU (2) AU2003258095A1 (de)
CA (1) CA2494236A1 (de)
WO (2) WO2004015071A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0328928D0 (en) * 2003-12-12 2004-01-14 Cancer Rec Tech Ltd Materials and methods relating to cell cycle control
WO2005100998A2 (de) * 2004-04-16 2005-10-27 Europroteome Ag Membrane markers for use in cancer diagnosis and therapie

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997042222A1 (en) * 1996-05-08 1997-11-13 Cyclacel Limited Methods and means for inhibition of cdk4 activity
US6180362B1 (en) * 1992-07-30 2001-01-30 Rhone-Poulenc Rorer S.A. Peptides which inhibit ras protein activity, their preparation and use
WO2001053493A2 (en) * 2000-01-18 2001-07-26 Lexicon Genetics Incorporated Human kinase protein and polynucleotides encoding the same
WO2001066594A2 (en) * 2000-03-06 2001-09-13 Sugen, Inc. Human protein kinases and protein kinase-like enzymes
WO2001088191A1 (en) * 2000-03-29 2001-11-22 The United States Of America As Represented By The Department Of Veterans Affairs A novel specific inhibitor of the cyclin kinase inhibitor p21?waf1/cip1¿
WO2002046384A2 (en) * 2000-12-06 2002-06-13 Incyte Genomics, Inc. Kinases and phosphatases sequences, and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762706A (en) * 1984-10-17 1988-08-09 Cetus Corporation Peptide antibodies and their use in detecting oncogene products

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180362B1 (en) * 1992-07-30 2001-01-30 Rhone-Poulenc Rorer S.A. Peptides which inhibit ras protein activity, their preparation and use
WO1997042222A1 (en) * 1996-05-08 1997-11-13 Cyclacel Limited Methods and means for inhibition of cdk4 activity
WO2001053493A2 (en) * 2000-01-18 2001-07-26 Lexicon Genetics Incorporated Human kinase protein and polynucleotides encoding the same
WO2001066594A2 (en) * 2000-03-06 2001-09-13 Sugen, Inc. Human protein kinases and protein kinase-like enzymes
WO2001088191A1 (en) * 2000-03-29 2001-11-22 The United States Of America As Represented By The Department Of Veterans Affairs A novel specific inhibitor of the cyclin kinase inhibitor p21?waf1/cip1¿
WO2002046384A2 (en) * 2000-12-06 2002-06-13 Incyte Genomics, Inc. Kinases and phosphatases sequences, and use thereof

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
GROSS S D ET AL: "Casein kinase I: spatial organization and positioning of a multifunctional protein kinase family", CELLULAR SIGNALLING, ELSEVIER SCIENCE LTD, GB, vol. 10, no. 10, November 1998 (1998-11-01), pages 699 - 711, XP002331674, ISSN: 0898-6568 *
GROSS STEFAN D ET AL: "A casein kinase I isoform is required for proper cell cycle progression in the fertilized mouse oocyte", JOURNAL OF CELL SCIENCE, vol. 110, no. 24, December 1997 (1997-12-01), pages 3083 - 3090, XP002392918, ISSN: 0021-9533 *
KITABAYASHI A N ET AL: "Cloning and Chromosomal Mapping of Human Casein Kinase I gamma2 (CSNK1G2)", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 46, no. 1, 15 November 1997 (1997-11-15), pages 133 - 137, XP004459098, ISSN: 0888-7543 *
KUSUDA J ET AL: "CLONING AND CHROMOSOME MAPPING OF THE HUMAN CASEIN KINASE I GAMMA3 GENE (CSNK1G3)", CYTOGENETICS AND CELL GENETICS, BASEL, CH, vol. 83, no. 1/2, 1998, pages 101 - 103, XP008052374, ISSN: 0301-0171 *
KUSUDA J ET AL: "Cloning, Expression analysis and chromosome mapping of human casein kinase 1 gamma 1 (CSNK1G1): Identification of two types of cDNA encoding the kinase protein associated with heterologous carboxy-terminal sequences", CYTOGENETICS AND CELL GENETICS, BASEL, CH, vol. 90, 2000, pages 298 - 302, XP002977055, ISSN: 0301-0171 *
MCKAY RENEE M ET AL: "The casein kinase I family in Wnt signaling", DEVELOPMENTAL BIOLOGY, vol. 235, no. 2, 15 July 2001 (2001-07-15), pages 388 - 396, XP002392920, ISSN: 0012-1606 *
WANG XIANGMIN ET AL: "Prenylated isoforms of yeast casein kinase I, including the novel Yck3p, suppress the gcs1 blockage of cell proliferation from stationary phase", MOLECULAR AND CELLULAR BIOLOGY, vol. 16, no. 10, 1996, pages 5375 - 5385, XP002392919, ISSN: 0270-7306 *
ZHAI L ET AL: "Casein Kinase I Gamma subfamily", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 270, no. 21, 26 May 1995 (1995-05-26), pages 12717 - 12724, XP002977054, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
AU2003258095A1 (en) 2004-02-25
WO2004015073A2 (en) 2004-02-19
WO2004015071A3 (en) 2004-08-12
AU2003263995A1 (en) 2004-02-25
CA2494236A1 (en) 2004-02-19
EP1534852A2 (de) 2005-06-01
WO2004015073A3 (en) 2005-12-29
JP2005534334A (ja) 2005-11-17
WO2004015071A2 (en) 2004-02-19
US20050251870A1 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
EP1572890A4 (de) Slc7s als modifikatoren des p53-wegs und verwendungsverfahren
EP1641809A4 (de) Verfahren und zusammensetzungen zum nachweis und zur auflistung genetischer variationen
EP1610772A4 (de) Retinoid-ersatz und opsin-agonisten und anwendungsverfahren dafür
EP1421384A4 (de) Hprp4s als modifikatoren des p53-wegs sowie verwendungsverfahren
EP1507541A4 (de) Hemmer und anwendungsverfahren dafür
EP1540126A4 (de) Schieferhydratationshemmmittel und verwendungsverfahren
EP1566999A4 (de) Mehrproduktion von öl und protein in pflanzen durch unterbrechung des phenylpropanoidwegs
EP1837925A4 (de) Niedertemperaturbehälter einer supraleitenden vorrichtung
EP1699218A4 (de) Präsenz-display-system und gateway-vorrichtung
EP1691812A4 (de) Gtpase-hemmer und anwendungsverfahren
EP1476150A4 (de) Carboxyfullerene und verwendungsverfahren dafür
EP1663255A4 (de) Withanamid und withanolid-zusammensetzungen und anwendungsverfahren dafür
EP1567515A4 (de) Neue lapachonverbindungen und verfahren zu deren anwendung
EP1899198A4 (de) Mechanismus zur lösbaren halterung und verwendungsverfahren
EP1417628A4 (de) Computergestützte verfahren zum entwerfen von molekülen
EP1538664A4 (de) Ätzmittel und ätzverfahren
FR2854483B1 (fr) Procede d'identification de sons specifiques
FR2849446B1 (fr) Vernis anti-salissures, procede d'application de ce vernis sur un support silicone et support ainsi traite
FR2864648B1 (fr) Procede de reveil d'un ordinateur autonome
EP1412746A4 (de) HADHs ALS MODIFIKATOREN DES P21-WEGS UND VERWENDUNGSVERFAHREN
EP1534852A4 (de) CSNK1GS ALS MODIFIKATOREN DES p21-WEGS UND VERWENDUNGSVERFAHREN
EP1802900A4 (de) Kontinuierliche chemische zufuhrvorrichtung und ihre verwendung
EP1651956A4 (de) Melks als modifikatoren des rac-wegs und verwendungsverfahren
EP1809307A4 (de) Medizinische lösung, verfahren zu ihrer herstellung und verwendung
EP1416904A4 (de) Hautexfoliationsverfahren

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050124

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

A4 Supplementary search report drawn up and despatched

Effective date: 20060822

17Q First examination report despatched

Effective date: 20070301

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070912